Homozygous HAX1 mutations in severe congenital neutropenia patients with sporadic disease: a novel mutation in two unrelated British kindreds

Patients with autosomal dominant (AD), sporadic and X‐linked severe congenital neutropenia (SCN) may have mutations in the elastase 2 (ELA2) or Wiskott‐Aldrich syndrome (WAS) genes. Homozygous mutations in the HAX1 gene have recently been reported in autosomal recessive (AR) cases of primarily Middle‐Eastern descent and the original Kostmann family. We screened 109 predominantly Caucasian SCN kindreds for mutations in these genes; 33 (30%) had 24 different ELA2 mutations, five of them novel, two kindreds (2%) had WAS mutations and four kindreds (4%) had three different HAX1 mutations, two of them novel. One HAX1 mutation (p.Ser43LeufsX11) was found in an AR Ashkenazi Jewish kindred, the other (p.Glu31LysfsX54) in two unrelated British patients with sporadic disease. Microsatellite analysis of the HAX1 locus revealed a common haplotype (maximum distance 4·1 Megabases) for the p.Glu31LysfsX54 patients, suggesting a possible ancestral founder. In functional assays, the level of spontaneous and staurosporine‐induced apoptosis was increased in neutrophils from both p.Ser43LeufsX11 patients but not a p.Glu31LysfsX54 patient, suggesting the possible presence of modifying factors. The low incidence of HAX1 mutations in our study suggests that the frequency may vary between racial groups but suggests that irrespective of inheritance or racial origin, SCN patients should be screened for HAX1 mutations.

[1]  D C Linch,et al.  Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. , 2001, Blood.

[2]  J. Opferman,et al.  Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons , 2008, Nature.

[3]  D. Linch,et al.  Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. , 2001, Blood.

[4]  C Bos,et al.  Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. , 2000, Blood.

[5]  Ronald McCarthy,et al.  Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis , 1998, Nature Medicine.

[6]  M. Ballmaier,et al.  Mutations in the gene encoding neutrophil elastase (ELA2) are not sufficient to cause the phenotype of congenital neutropenia , 2001, British journal of haematology.

[7]  L. Blancas Galicia,et al.  [Severe congenital neutropenia]. , 2010, Revista alergia Mexico.

[8]  J. Gabrilove,et al.  A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. , 1993, Blood.

[9]  Stephen J Salipante,et al.  Neutrophil elastase in cyclic and severe congenital neutropenia. , 2007, Blood.

[10]  Bodo Grimbacher,et al.  Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. , 2008, Blood.

[11]  K. Welte,et al.  Severe congenital neutropenia. , 2006, Seminars in hematology.

[12]  Fernando Rodrigues-Lima,et al.  Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. , 2004, Blood.

[13]  Jun Xia,et al.  Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis. , 2006, Blood.

[14]  Bengt Fadeel,et al.  HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease) , 2007, Nature Genetics.

[15]  H. Cutting,et al.  INFANTILE GENETIC AGRANULOCYTOSIS. , 1965, Pediatrics.

[16]  P. Rosenberg,et al.  Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia , 2007, British journal of haematology.

[17]  George Eliopoulos,et al.  Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2 , 2003, Nature Genetics.

[18]  David C. Dale,et al.  Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis , 1999, Nature Genetics.

[19]  O. Ohara,et al.  Severe developmental delay and epilepsy in a Japanese patient with severe congenital neutropenia due to HAX1 deficiency , 2007, Haematologica.

[20]  Rolf Kostmann,et al.  INFANTILE GENETIC AGRANULOCYTOSIS , 1975 .

[21]  A. Schäffer,et al.  Genetic heterogeneity in severe congenital neutropenia: how many aberrant pathways can kill a neutrophil? , 2007, Current opinion in allergy and clinical immunology.

[22]  Koenraad Devriendt,et al.  Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia , 2001, Nature Genetics.

[23]  D. Link,et al.  Severe congenital neutropenia and the unfolded protein response , 2008, Current opinion in hematology.

[24]  Holger Heyn,et al.  Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. , 2006, Blood.

[25]  Christine Kinnon,et al.  Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. , 2006, Blood.